Pattern of nosocomial infection in two intensive care units of a tertiary care hospital in Karachi

Journal of the College of Physicians and Surgeons Pakistan

Volumn 18, Issue 2, 2008, Pages 134-

  Mirza, Irfan Ali ^a  

^a Combined Military Hospital ^*  (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFTAZIDIME; IMIPENEM; OXACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SODIUM CHLORIDE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM CULTURE; BACTERIUM ISOLATION; HOSPITAL INFECTION; HUMAN; IN VITRO STUDY; INTENSIVE CARE UNIT; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PAKISTAN; PSEUDOMONAS AERUGINOSA; TERTIARY HEALTH CARE;

BACTERIAL INFECTIONS; CROSS INFECTION; HUMANS; INTENSIVE CARE UNITS; METHICILLIN RESISTANCE; PAKISTAN; RISK FACTORS; STAPHYLOCOCCUS AUREUS;

EID: 42149095400     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Ferraro MJ, Craig WA, Dudley MN, Eliopoulos GM, Hecht DW, Hindler J, et al. Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A7. 7th ed. Wayne, PA: National Committee for Clinical Lab Standards; 2000.
2. Guignard B, Entenza JM, Moreillon P. Beta-lactams against methicillin-resistants Staphylococcus aurew. Curr Opin Pharmacol 2005: 5: 479-89.
3. Zelenitsky SA, Harding GK, Sun S, Ubhi K, Ariano RE. Treatment and outcome of Pseudonsonas aeruginosa bacteraemia: an antibiotic pharmacodynamic analysis. J Antimkrob Chemother 2003; 52:668-74.
4. Livermore DM, Mushtaq S, James D, Potz N, Walker RA, Charlett A, et al. In vitro activity of piperacillin/tazobactam and other broad spectrum antibiotics against bacteria from hospitalised patients in the British Isles. Int J Antimicrob Agents 2003; 22: 14-24.
5. Karlowsky JA, Draghi DC, Jones ME, Thornsberry C, Friedland IR, Sahm DF. Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001. Antimicrob Agents Chemother 2003; 47: 1681-8.